Beta Expansion WellBrain is in invitation-only beta with a focus on real-time cognitive assessment and non-opiate treatment modalities, presenting a sales opportunity to engage physician networks seeking innovative pain and anxiety management tools.

Medical Expertise Product development is led by clinicians from Harvard, Stanford, and Mayo Clinic with heavy clinical validation potential, making it easier to approach health systems and medical groups that value evidence-based, physician-endorsed solutions.

Acquisition Readiness Recent acquisition of Mevoked signals an appetite for integrating behavioral analytics and multiprogram capabilities, suggesting potential cross-sell or upsell for analytics, perinatal mental health, and chronic pain pathways.

Tech Stack Utilizes scalable platforms (AWS, HubSpot, WordPress/Wix, MySQL) enabling integrations with existing EMR, CRM, and content systems, offering talking points for IT and procurement teams about deployment ease and data workflows.

Revenue-Level Current revenue range ($1M-$10M) and small team size (2-10 employees) indicate a nimble organization with potential for partner-led pilots, co-marketing, and accelerated deployment to expand market reach in wellness, chronic pain, and anxiety care.